MiR-22 regulates 5-FU sensitivity by inhibiting autophagy and promoting apoptosis in colorectal cancer cells

H Zhang, J Tang, C Li, J Kong, J Wang, Y Wu, E Xu… - Cancer letters, 2015 - Elsevier
Autophagy has become one of the most important mechanisms of chemotherapy resistance
by supporting the survival of tumor cells under metabolic and therapeutic stress. Here, we …

[HTML][HTML] miR-31 affects colorectal cancer cells by inhibiting autophagy in cancer-associated fibroblasts

X Yang, X Xu, J Zhu, S Zhang, Y Wu, Y Wu, K Zhao… - Oncotarget, 2016 - ncbi.nlm.nih.gov
Autophagy is a double-edged sword in tumor development. Recent studies have found that
miRNAs have an inhibitory effect on the regulation of autophagy. It has been reported that …

miR-15b-5p resensitizes colon cancer cells to 5-fluorouracil by promoting apoptosis via the NF-κB/XIAP axis

C Zhao, Q Zhao, C Zhang, G Wang, Y Yao, X Huang… - Scientific reports, 2017 - nature.com
Drug resistance, which is closely correlated with an imbalance in apoptosis, endows
colorectal cancer (CRC) with enhanced progression capacity irrespective of the treatment …

[HTML][HTML] The c-Myc/miR-27b-3p/ATG10 regulatory axis regulates chemoresistance in colorectal cancer

W Sun, J Li, L Zhou, J Han, R Liu, H Zhang, T Ning… - Theranostics, 2020 - ncbi.nlm.nih.gov
Oxaliplatin (OXA) resistance is the major obstacle to the anticancer effects of chemotherapy
in colorectal cancer (CRC) patients. MicroRNAs (miRNAs) play an important role in the …

miR-206 regulates 5-FU resistance by targeting Bcl-2 in colon cancer cells

X Meng, R Fu - OncoTargets and therapy, 2018 - Taylor & Francis
Introduction Previous studies have found that miRNAs play a key role in drug resistance.
Multiple reports show that miRNAs act as regulators in colorectal cancer (CRC) cells, but the …

miR-23b-3p regulates the chemoresistance of gastric cancer cells by targeting ATG12 and HMGB2

Y An, Z Zhang, Y Shang, X Jiang, J Dong, P Yu… - Cell Death & …, 2015 - nature.com
Chemotherapy is an important treatment modality for gastric cancer (GC); however, it usually
fails because of drug resistance, especially multidrug resistance (MDR). Previously, we …

METTL14-dependent maturation of pri-miR-17 regulates mitochondrial homeostasis and induces chemoresistance in colorectal cancer

K Sun, L Chen, Y Li, B Huang, Q Yan, C Wu, Q Lai… - Cell Death & …, 2023 - nature.com
Abstract miR-17-5p has been found to be involved in the proliferation and metastasis of
colorectal cancer (CRC), and N 6-methyladenosine (m6A) modification is the most common …

miR‑221 inhibits autophagy and targets TP53INP1 in colorectal cancer cells

D Liao, T Li, C Ye, L Zeng, H Li… - Experimental and …, 2018 - spandidos-publications.com
Colorectal cancer (CRC) is the third most common cancer and the fourth leading cause of
cancer‑associated mortalities worldwide. MicroRNAs (miRNAs/miRs) serve important roles …

miR-338-3p confers 5-fluorouracil resistance in p53 mutant colon cancer cells by targeting the mammalian target of rapamycin

J Han, J Li, K Tang, H Zhang, B Guo, N Hou… - Experimental cell …, 2017 - Elsevier
Evidence demonstrate that p53 mutations and microRNAs (miRs) are important components
of 5-FU resistance in colorectal cancer (CRC). miR-338-3p has been reported associated …

[HTML][HTML] MiR-361-5p suppresses chemoresistance of gastric cancer cells by targeting FOXM1 via the PI3K/Akt/mTOR pathway

L Tian, Z Zhao, L Xie, JP Zhu - Oncotarget, 2018 - ncbi.nlm.nih.gov
Gastric cancer is a prevalent cancer and chemotherapy is a main treatment for patients.
Docetaxel is commonly used as a chemotherapeutic drug for gastric cancer patients. With …